Payer PolicyActive
SURG.00156 Implanted Artificial Iris Devices
ANTHEM-SURG.00156
Anthem
Effective: October 1, 2025
Updated: December 30, 2025
Policy Summary
This policy addresses implanted artificial iris devices used to treat iris defects, including congenital aniridia and traumatic iris loss. Anthem considers artificial iris implantation investigational and not medically necessary; therefore, it is not covered for any indication. No exceptions or covered circumstances are listed, and the non-coverage applies regardless of cause or clinical presentation.
Coverage Criteria Preview
Key requirements from the full policy
"The use of implanted artificial iris devices are consideredinvestigational and not medically necessaryfor all indications, including as a treatment of congenital or traumatic aniridia."
Sign up to see full coverage criteria, indications, and limitations.